Cellceutix Pharma Inc is categorized under Research and Development Laboratories in Beverly, MA and active since 2008.
Cellceutix Pharma Inc was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Leo W Ehrlich at the company’s single location by writing to 100 Cummings Center # 151b, Beverly, Massachusetts MA 01915 or by phoning (978) 236-8717. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cellceutix Pharma Inc |
| Contact Person: | Leo W Ehrlich |
| Address: | 100 Cummings Center # 151b, Beverly, Massachusetts 01915 |
| Phone Number: | (978) 236-8717 |
| Website Address: | cellceutix.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 3254120 |
| Share This Business: |
Cellceutix Pharma Inc was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Leo W Ehrlich for inquiries that concern Cellceutix Pharma Inc by calling the company number (978) 236-8717, as your correspondence is most welcome. Additionally, the physical location of the single location of Cellceutix Pharma Inc can be found at the coordinates 42.5685,-70.8619 as well as the street address 100 Cummings Center # 151b in Beverly, Massachusetts 01915.
For its online presence, you may visit Cellceutix Pharma Inc’s website at cellceutix.com and engage with its social media outlets through on Twitter and on Facebook.